In 2014, Sayyah's group published the first study showing that this small G-protein is required for glioblastoma cell growth in vitro by activating downstream signaling of G-protein-coupled receptor and RhoA utilizing Rap1 knockdown techniques. This evidence concerns the gene RAP1A and glioblastoma.